公开(公告)号：US20230065921A1

公开(公告)日：2023-03-02

申请号：US17821688

申请日：2022-08-23

Applicant: UCB Biopharma SRL

Inventor： Helene Margaret FINNEY ,  Stephen Edward RAPECKI ,  Kerry Louise TYSON ,  Michael John WRIGHT

IPC: C07K16/28 ,  A01K67/027

Abstract: The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.

公开(公告)号：US20200157215A1

公开(公告)日：2020-05-21

申请号：US16778523

申请日：2020-01-31

Applicant: UCB Biopharma SRL

Inventor： Helene Margaret FINNEY ,  Stephen Edward RAPECKI ,  Kerry Louise TYSON ,  Michael John WRIGHT

IPC: C07K16/28 ,  A01K67/027

Abstract: The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.

公开(公告)号：US20230287134A1

公开(公告)日：2023-09-14

申请号：US18153181

申请日：2023-01-11

Applicant: UCB BIOPHARMA SRL

Inventor： Helene Margaret FINNEY ,  Stephen Edward RAPECKI ,  Kerry Louise TYSON ,  Michael John WRIGHT

IPC: C07K16/28 ,  C07K16/18

CPC classification number: C07K16/289 ,  C07K16/18 ,  C07K16/2803 ,  C07K2317/31 ,  C07K2317/55 ,  C07K2317/622 ,  C07K2317/24 ,  C07K2317/76 ,  C07K2317/90 ,  C07K2317/35 ,  C07K2317/64 ,  C07K2317/624

Abstract: The present disclosure relates to constructs, such as antibody molecules comprising a binding domain specific to CD45, said binding domain comprising SEQ ID NO: 1, 2, 3 and/or SEQ ID NO: 4, 5 and 6. The disclosure also extends to pharmaceutical compositions comprising said constructs and use of the constructs/compositions in treatment.